Magnolia Medical Technologies
PrivateLast Round
Growth Equity
Feb 16, 2022
Total Funding Raised
$116M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Magnolia Medical Technologies is a healthcare company that develops blood-collection systems designed to eliminate sepsis misdiagnosis by preventing false-positive blood culture results through a sterile, closed collection process.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Magnolia Medical Technologies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Magnolia Medical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Feb 16, 2022 | ||||
| Debt | May 27, 2020 | ||||
| Series C | Jan 30, 2019 | ||||
| Series B Extension | Apr 4, 2017 | ||||
| Series B | Jul 13, 2016 | ||||
Series A | Nov 1, 2014 |
Key People
Founding team and executive leadership
Magnolia Medical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Growth Equity |
| Evidity Health Capital | Growth Equity, Series C |
| SightLine Partners | Growth Equity, Series C |
| Horizon Technology Finance Corporation | Debt |
| Sectoral | Growth Equity |
| RTW Investments | Growth Equity, Series C |
| Band of Angels | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Company holds over 70 issued patents with 50+ applications pending.
- Apr 1, 2026
Steripath device receives FDA-cleared indication for reducing blood culture contamination.
Magnolia Medical Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Magnolia Medical Technologies's valuation, stock price, and market status.